IOVANCE BIOTHERAPEUTICS, INC. (IOVA)

SEC filing

IOVANCE BIOTHERAPEUTICS, INC.

IOVA · CIK 1425205

4 · Sep 10, 2026 · Chief Regulatory Officer Puri Raj K. exercised options for 9,766 shares; reported 4,478 shares

Chief Regulatory Officer Puri Raj K. exercised options for 9,766 shares; reported 4,478 shares

OWNERSHIP DOCUMENT

xslF345X06/tm2625111-1_4seq1.xmlSEC.gov

Graphics and non-inline formats (not embedded below).